John Mullinax MD FACS

General Surgery•Tampa, FL

Surgical Oncology (Other than Breast)

Associate Member, Section Head, Surgical Oncology Sarcoma Department Immunology Program Surgical Director, Cell Therapy Program H. Lee Moffitt Cancer Center

Request appointment

12902 USF Magnolia DriveTampa, FL 33612
Book by Phone+1(659) 247-5395

Overview of Dr. Mullinax

Dr. John Mullinax is a general surgeon in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute and Tampa General Hospital. He received his medical degree from University of South Florida College of Medicine and has been in practice 19 years. He is one of 94 doctors at H. Lee Moffitt Cancer Center and Research Institute and one of 162 doctors at Tampa General Hospital who specialize in General Surgery. He has more than 70 publications and over 500 citings.

Education & Training

University of South Florida Morsani/Moffitt Cancer CenterFellowship, Complex General Surgical Oncology, 2014 - 2016
University of South Florida MorsaniResidency, Surgery, 2007 - 2014
National Cancer Institute2010 - 2012
University of South Florida College of MedicineClass of 2007

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2010 - 2028
American Board of Surgery Surgery
American Board of Surgery Complex General Surgical Oncology

Awards, Honors, & Recognition

Resident of the Year Department of Surgery, USF College of Medicine, 2012-2013

Clinical Trials

REtroperitoneal SArcoma Registry: an International Prospective Initiative Start of enrollment: 2016 Sep 01
RECRUITING
Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma Start of enrollment: 2019 Aug 20
TERMINATED
PHASE2
Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma Start of enrollment: 2019 Sep 27
COMPLETED
PHASE1

Publications & Presentations

PubMed

Invited Editorial about Article: "Salvage Metastasectomy after Adoptive Cell Transfer for Melanoma: Long-Term Updates" by Dinerman, Aaron et al.
Samantha Seitter, John E Mullinax
Annals of Surgical Oncology. 2026-09-01
Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma.
Lilit Karapetyan, Jin Xu, Kimberly Ward, Denise Kalos, Benjamin Schachner
Med. 2026-08-14
2 citations
Safety and Efficacy of Tumor-Infiltrating Lymphocyte Therapy with Reduced-Dose Lymphodepleting Conditioning in High-Risk Metastatic Melanoma Patients.
Lilit Karapetyan, Joel Kuriakose, Elizabeth DiMaggio, Kimberly Ward, Jamie Chau
Transplantation and Cellular Therapy. 2026-03-01

Abstracts/Posters

Tumor Inflammation and Myeloid Derived Suppressor Cells Reduce the Efficacy of CD19 CAR T Cell Therapy in Lymphoma
John E Mullinax, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell Therapy
John E Mullinax, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Researchers at Johns Hopkins All Children’s Seek to Adapt Adult Treatments to Fight Pediatric CancersSeptember 6th, 2019
Chemotherapy Approach Avoids Amputation in Sarcoma PatientsMarch 22nd, 2017
Three Nonprofit Organizations Step up to Fund Unique Pediatric Cancer Clinical TrialDecember 26th, 2023